Azelaic acid foam, 15% (BAY39-6251) + Vehicle foam

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Papulopustular Rosacea

Conditions

Papulopustular Rosacea

Trial Timeline

Sep 1, 2012 → Jan 1, 2014

About Azelaic acid foam, 15% (BAY39-6251) + Vehicle foam

Azelaic acid foam, 15% (BAY39-6251) + Vehicle foam is a phase 3 stage product being developed by Bayer for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT01555463. Target conditions include Papulopustular Rosacea.

What happened to similar drugs?

3 of 12 similar drugs in Papulopustular Rosacea were approved

Approved (3) Terminated (1) Active (8)
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3
Azelaic Acid foam 15%BayerApproved
S5G4T-1Sol-Gel TechnologiesPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01555463Phase 3Completed

Competing Products

18 competing products in Papulopustular Rosacea

See all competitors
ProductCompanyStageHype Score
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
29
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
27
Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3
40
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
40
Azelaic Acid foam 15%BayerApproved
40
Azelaic acid + Vehicle foamBayerPhase 2
32
Azelaic acid foam 15% + Vehicle foamBayerPhase 2
32
azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
40
Azelaic Acid Foam + Azelaic Acid GelBayerPhase 1
26
Encapsulated Benzoyl Peroxide CreamSol-Gel TechnologiesPhase 1
19
S5G4T-1Sol-Gel TechnologiesPhase 3
22
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
30
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
30
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
30
FMX103 1.5%Vyne TherapeuticsPhase 3
30
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
30